Literature DB >> 22729302

Oxidative stress and inflammatory response increase during coronary artery bypass grafting with extracorporeal circulation.

Flora Eli Melek1, Liz Andréa Villela Baroncini, João Carlos Domingus Repka, Celso Soares Nascimento, Dalton Bertolim Précoma.   

Abstract

INTRODUCTION: Thiobarbituric acid-reactive substance is a marker of oxidative stress and has cytotoxic and genotoxic actions. C- reactive protein is used to evaluate the acute phase of inflammatory response.
OBJECTIVES: To assess the thiobarbituric acid-reactive substance and C-reactive protein levels during extracorporeal circulation in patients submitted to cardiopulmonary bypass.
METHODS: Twenty-five consecutive surgical patients (16 men and nine women; mean age 61.2 ± 9.7 years) with severe coronary artery disease diagnosed by angiography scheduled for myocardial revascularization surgery with extracorporeal circulation were selected. Blood samples were collected immediately before initializing extracorporeal circulation, T0; in 10 minutes, T10; and in 30 minutes, T30.
RESULTS: The thiobarbituric acid-reactive substance levels increased after extracorporeal circulation (P=0.001), with average values in T0=1.5 ± 0.07; in T10=5.54 ± 0.35; and in T30=3.36 ± 0.29 mmoles/mg of serum protein. The C-reactive protein levels in T0 were negative in all samples; in T10 average was 0.96 ± 0.7 mg/dl; and in T30 average was 0.99 ± 0.76 mg/dl. There were no significant differences between the dosages in T10 and T30 (P=0.83).
CONCLUSIONS: C-reactive protein and thiobarbituric acid-reactive substance plasma levels progressively increased during extracorporeal circulation, with maximum values of thiobarbituric acid-reactive substance at 10 min and of C-reactive protein at 30 min. It suggests that there are an inflammatory response and oxidative stress during extracorporeal circulation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22729302     DOI: 10.5935/1678-9741.20120010

Source DB:  PubMed          Journal:  Rev Bras Cir Cardiovasc


  9 in total

1.  Evaluation of Oxidative Status in Elderly Patients with Multiple Cerebral Infarctions and Multiple Chronic Total Coronary Occlusions.

Authors:  Xia Li; Dianxuan Guo; Youdong Hu; Ying Chen
Journal:  Dis Markers       Date:  2022-06-28       Impact factor: 3.464

2.  A comparison of the oxidative stress response in single-incision laparoscopic versus multi-trocar laparoscopic totally extraperitoneal inguinal hernia repair.

Authors:  Jacek T Białecki; Waldemar Myszka; Ewa Wysocka; Sebastian Sowier; Przemysław Pyda; Ryszard Antkowiak; Łukasz Antkowiak; Anna Sowier; Zbigniew Krasiński
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-02-24       Impact factor: 1.195

3.  Oxidative stress in coronary artery bypass surgery.

Authors:  Amaury Edgardo Mont'Serrat Ávila Souza Dias; Petr Melnikov; Lourdes Zélia Zanoni Cônsolo
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jul-Aug

4.  ADMA, SDMA and L-arginine may be Novel Targets in Pharmacotherapy for Complications due to Cardiopulmonary Bypass.

Authors:  Aydın Kahraman; Emre Mutlu; Mustafa Aldağ
Journal:  J Med Biochem       Date:  2017-01-25       Impact factor: 3.402

5.  Exercise through a cardiac rehabilitation program attenuates oxidative stress in patients submitted to coronary artery bypass grafting.

Authors:  José Francisco Taty Zau; Rodrigo Costa Zeferino; Nádia Sandrine Mota; Gerez Fernandes Martins; Salvador Manoel Serra; Therezil Bonates da Cunha; Daniel Medeiros Lima; Basilio de Bragança Pereira; Emília Matos do Nascimento; Danilo Wilhelm Filho; Rozangela Curi Pedrosa; Roberto Coury Pedrosa
Journal:  Redox Rep       Date:  2017-12-27       Impact factor: 4.412

6.  The Predictor Potential Role of the Glucose to Potassium Ratio in the Diagnostic Differentiation of Massive and Non-Massive Pulmonary Embolism.

Authors:  Ferit Boyuk
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

7.  Alpha lipoic acid attenuates inflammatory response during extracorporeal circulation.

Authors:  Ihsan Sami Uyar; Suleyman Onal; M Besir Akpinar; Ibak Gonen; Veysel Sahin; Abdulhadi Cihangir Uguz; Oktay Burma
Journal:  Cardiovasc J Afr       Date:  2013-09       Impact factor: 1.167

8.  Tadalafil: Protective Action against the Development of Multiple Organ Failure Syndrome.

Authors:  Granville G de Oliveira; Samer A H de Oliveira; Paulo Henrique H Botelho; Marcos Aurelio Barboza de Oliveira; Ka Bian; Ferid Murad
Journal:  Braz J Cardiovasc Surg       Date:  2017 Jul-Aug

9.  Extracorporeal Hemadsorption versus Glucocorticoids during Cardiopulmonary Bypass: A Prospective, Randomized, Controlled Trial.

Authors:  Gordana Taleska Stupica; Maja Sostaric; Marija Bozhinovska; Lea Rupert; Zoran Bosnic; Ales Jerin; Alojz Ihan; Tomislav Klokocovnik; Matej Podbregar
Journal:  Cardiovasc Ther       Date:  2020-03-27       Impact factor: 3.023

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.